Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Cyto365 Ab |
| Country | Sweden |
| Start Date | Nov 01, 2022 |
| End Date | Apr 30, 2025 |
| Duration | 911 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190103560 |
CYTO365 is developing RondeO® - a revolutionary medical stopcock to be used with intravenous drug administration sets (IV sets).
RondelO® is the first medical device that allows for a sequential intravenous administration of up to 6 drugs with the neutral saline in between the drugs.
RondelO® aids the nurse to administer drugs to the patient safely and correctly, by letting only one drug pass at a time.
It solves the problem of serious side effects caused by drug incompatibility by eliminating human error and unwanted parallel infusion and thereby increases patient safety.
Moreover, RondelO® is easy to use (minimal training required), safe for the user (Closed System Valve (CSV) minimizes hazardous drug expose for the nurse), customizable (different configurations with 2, 4 or 6 drug inlets with or without CSV available) and time-efficient (all drugs are connected to IV set at the beginning of the procedure).
Cyto365 Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant